Connection
John Somberg to Research
This is a "connection" page, showing publications John Somberg has written about Research.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.692 |
|
|
|
-
Somberg JC. Have we maxed out on new therapies. Am J Ther. 2011 Mar-Apr; 18(2):91.
Score: 0.502
-
Somberg JC. Clinical research oversight. Am J Ther. 2002 Mar-Apr; 9(2):85.
Score: 0.269
-
Somberg JC. A new therapeutic millennium [correction of millenium]. Am J Ther. 2001 Nov-Dec; 8(6):385-6.
Score: 0.263
-
Somberg JC. Stem-cell research. Am J Ther. 2001 Sep-Oct; 8(5):307.
Score: 0.260
-
Somberg JC. Do we need to accredit clinical research? Am J Ther. 2001 Jul-Aug; 8(4):223-4.
Score: 0.257
-
Somberg JC. Is clinical research oversight adequate in the United States? Am J Ther. 2000 Sep; 7(5):283-4.
Score: 0.243
-
Somberg JC. What's gone wrong with clinical research. Am J Ther. 2000 Mar; 7(2):49-50.
Score: 0.234
-
Somberg JC. International symposium on drug development. Am J Ther. 1999 Sep; 6(5):289.
Score: 0.226
-
Somberg J. OUS results, clinical studies and therapeutic innovation in America. Am J Ther. 2014 Jul-Aug; 21(4):233.
Score: 0.158
-
Somberg JC. The hubris of science: defending the scientific process from political agendas. Am J Ther. 2010 Jan-Feb; 17(1):1.
Score: 0.116
-
Somberg J. FDA user fees and innovation. Am J Ther. 2008 Mar-Apr; 15(2):97.
Score: 0.102
-
Somberg JC. The cost of therapy. Am J Ther. 2000 Nov; 7(6):343-4.
Score: 0.061